Author(s):
Mayur Bhamare, Rushikesh Bachhav, Ganesh Sonawane, Sunil Mahajan, Vijayraj Sonawane
Email(s):
mayurbhamare0404@gmail.com
DOI:
10.52711/2231-5659.2026.00020 
Address:
Mayur Bhamare, Rushikesh Bachhav, Ganesh Sonawane, Sunil Mahajan, Vijayraj Sonawane
Divine College of Pharmacy, Department of Pharmaceutical Quality Assurance, Satana.
*Corresponding Author
Published In:
Volume - 16,
Issue - 2,
Year - 2026
ABSTRACT:
The superfamily of heme-containing proteins known as cytochrome P450 (CYP) enzymes is essential to the metabolism of many different endogenous and exogenous substances, including medications. Individual differences in CYP enzyme activity have a substantial impact on medication safety and efficacy, which can result in adverse drug reactions (ADRs) and drug-drug interactions (DDIs). The structure, function, and control of CYP enzymes, their involvement in drug metabolism, the mechanisms behind DDIs, and the clinical consequences for pharmacotherapy are all thoroughly examined in this study. It also covers methods for anticipating and controlling DDIs in order to maximise therapeutic results.
Cite this article:
Mayur Bhamare, Rushikesh Bachhav, Ganesh Sonawane, Sunil Mahajan, Vijayraj Sonawane. Comprehensive Analysis of Cytochrome p450 Enzymes: Roles in Drug Metabolism and Drug-Drug Interactions. Asian Journal of Research in Pharmaceutical Sciences.2026; 16(2):126-0. doi: 10.52711/2231-5659.2026.00020
Cite(Electronic):
Mayur Bhamare, Rushikesh Bachhav, Ganesh Sonawane, Sunil Mahajan, Vijayraj Sonawane. Comprehensive Analysis of Cytochrome p450 Enzymes: Roles in Drug Metabolism and Drug-Drug Interactions. Asian Journal of Research in Pharmaceutical Sciences.2026; 16(2):126-0. doi: 10.52711/2231-5659.2026.00020 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2026-16-2-5
REFERANCE:
1. Inaba T, Kovacs PB. Cytochrome P450 enzymes and drug metabolism. CMAJ. 2010; 182(5):523-8.
2. Guengerich FP. Cytochrome P450 and chemical toxicology. Chem Res Toxicol. 2008; 21(1):70-83.
3. Zhou SF, Liu JP, Choubey B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev. 2009; 41(2):89-295.
4. Wienkers LC, Heath TG. Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov. 2005; 4(10):825-33.
5. Rendic S, Di Carlo FJ. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev. 1997; 29(1-2):413-580.
6. Guengerich FP. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol. 2001; 14(6):611-50.
7. Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013; 138(1):103-41.
8. Zanger UM, Klein K. Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): Advances and future directions. Front Genet. 2013; 4:24.
9. Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer. 2006; 6(12): 947-60.
10. Guengerich FP. Cytochrome P450 and chemical toxicity. Chem Biol Interact. 2004; 147(3):53-67.
11. Wilkinson GR. Drug metabolism and variability among patients in drug response. N Engl J Med. 2005; 352(21): 2211-21.
12. Rodrigues AD. Drug-drug interactions. Pharmacokinetic and pharmacodynamic drug-drug interactions. Clin Pharmacokinet. 1999; 36(1): 59-73.
13. Evans WE, Relling MV. Pharmacogenomics: Translating functional genomics into rational therapeutics. Science. 1999; 286(5439): 487-91.
14. Bhutani KK, Gohil VM. Natural products drug discovery research in India: Status and appraisal. Indian J Exp Biol. 2010; 48(3): 199-207.
15. Burk O, Wojnowski L. Cytochrome P450 3A and its regulation. Naunyn Schmiedebergs Arch Pharmacol. 2004; 369(1): 105-24.
16. Crettol S, Petrovic N, Murray M. Pharmacogenetics of phase I and phase II drug metabolism. Curr Pharm Des. 2010; 16(2): 204-19.
17. Shou M, Korzekwa KR, Crespi CL, Gonzalez FJ, Gelboin HV, Waxman DJ. The role of specific human cytochrome P450 enzymes in the oxidative metabolism of paclitaxel (Taxol). Drug Metab Dispos. 1997; 25(12): 1311-9.
18. Murray GI. The role of cytochrome P450 in drug resistance. Curr Opin Pharmacol. 2006; 6(4): 378-89.
19. Zanger UM, Turpeinen M, Klein K, Schwab M. Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem. 2008; 392(6): 1093-108.
20. Ma Q, Lu AY. Origins of individual variability in P4501A induction. Chem Res Toxicol. 2003; 16(3): 249-60.
21. Hudlicky T. Introduction to enzymes in synthesis. Chemical reviews. 2011 Jul 13; 111(7): 3995-7.
22. Moderation of the Plasma Chemistry and Hematological Indices of Normal and Salt-loaded Rats by an Aqueous Extract of the Rhizomes of Sansevieria Liberica: Implications for the Management of Hypertension and Associated Complications. Asian J. Pharm. Res. 2013; 3(3): 134-140.
23. Nandhini S, Radha R , Vadivu R. Docking of Hematoporphyrin on Various Anticancer Drugs Targeting Enzymes. Asian J. Pharm. Res. 2016; 6(3): 123-130.
24. Mayur S. Jain, Shashikant D. Barhate, Bhushan P. Gayakwad, Prafull P. Patil. Olaparib is an inhibitor of poly (ADP-Ribose) polymerase (PARP) Enzymes: A Review. Asian J. Pharm. Res. 2018; 8(2): 110-112.
25. Sandip S. Kshirsager, Dr. Siraj N. Shaikh, Narendra B. Patil, Ketan B. Patil. Novel Molecule of Protein Tyrosine Kinase Enzyme Inhibitor in Treatment of Breast Cancer: Neratinib Maleate. Asian J. Res. Pharm. Sci. 2020; 10(2):100-102.
26. Sarika V. Khandbahale, Kanchan R. Pagar, Rupali. V. Khankari. Introduction to Enzymes. Asian J. Res. Pharm. Sci. 2019; 9(2): 123-130.
27. I.E. Otuokere. Molecular Mechanics Potential Energy Function of Angiotensin-Converting Enzyme (ACE) inhibitor, Lisinopril. Asian J. Res. Pharm. Sci. 2014; 4(3): 118-124.
28. Vaishali Vijay Pagar, Mitesh P. Sonawane, Parag D. Kothawade, Pratibha K. Pagar, Shamal S. Patil. Formulation Development and Evaluation of Ubidecarenone Chewable Tablet. Asian Journal of Research in Pharmaceutical Sciences. Sci. 2024; 14(1): 6-0.
29. Abhijit Ray. Application of Lipase in Industry. Asian J. Pharm. Tech. 2012; 2(2): 33-37.
30. M. Seenuvasan, N. Balaji, M. Anil Kumar. Review on Enzyme Loaded Magnetic Nanoparticles. Asian J. Pharm. Tech. 2013;3(4): 200-208.
31. Wajid Ahmad, Rihan Jawed, Irfan Khan, Rizwan Khallel, Danish Hakam. A Review on Poly (ADP-ribose) Polymerase (PARP) - An Enzyme that Share the ability to Catalyze the Transfer of ADP-Ribose to Target Proteins. Asian Journal of Pharmacy and Technology. 2023; 13(3):223-8.
32. Soram Ibomcha Singh, Shashi Prabha. Synthesis, Identification of Some P-Chiral Organic Phosphoramidates and Their Inhibitory Action towards Enzymes. Asian J. Research Chem. 2009; 2(4): 523-525.
33. Yatri R Shah, Dhrubo Jyoti Sen, CN Patel. Biochemical Role of Cytochrome P450 Enzymes In-Vivo. Asian J. Research Chem. 2010; 3(2): 243-248.
34. Ubani Chibuike Samuel, Joshua Parker Elijah. Biochemical Assessment of Kerosene Contaminated Diet on the Liver Enzyme Markers of Albino Rats. Asian J. Research Chem. 2010; 3(3): 795-800.
35. Anna Pratima Nikalje, Amogh C. Tathe, Mangesh S. Ghodke. Biocatalysis: A Brief Review. Asian J. Research Chem. 2011; 4(9): 1355-1360.